Zomedica Corp.
ZOM was delisted on the 4th of March, 2025.
12 hedge funds and large institutions have $1.61M invested in Zomedica Corp. in 2018 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
133% more capital invested
Capital invested by funds: $689K → $1.61M (+$918K)
33% more funds holding
Funds holding: 9 → 12 (+3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$708K |
| 2 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
+$56.4K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$55.6K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$13.5K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$11.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$52K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$7.83K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Millennium Management
New York
| $895K | +$708K | +345,259 | +563% |
|
2
Cambridge Investment Research Advisors
Fairfield,
Iowa
| $428K | – | – | – |
|
|
JA
3
JVL Associates
Wyoming,
Michigan
| $129K | – | – | – |
|
|
SPC
4
Sigma Planning Corp
Ann Arbor,
Michigan
| $61K | +$56.4K | +27,500 | New |
|
|
5
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $59K | +$55.6K | +27,079 | New |
|
|
6
Wells Fargo
San Francisco,
California
| $15K | +$11.8K | +5,750 | +451% |
|
|
7
Bank of America
Charlotte,
North Carolina
| $14K | +$13.5K | +6,573 | New |
|
8
Royal Bank of Canada
Toronto,
Ontario, Canada
| $5K | +$632 | +308 | +15% |
|
|
NWM
9
Northwest Wealth Management
Spencer,
Iowa
| $1K | +$574 | +280 | New |
|
|
10
Citadel Advisors
Miami,
Florida
| – | -$52K | -26,090 | Closed |
|
|
11
UBS Group
Zurich,
Switzerland
| – | -$7.83K | -3,815 | -99% |
|
ZOM Hedge Fund Activity: Q1 2018 in Review
12 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q1 2018, worth a combined $1.61M — up 133% from $689K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new ZOM positions and 1 closed out — a net gain of 3 holders — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Millennium Management, adding an estimated $708K. The largest seller was Citadel Advisors, exiting entirely with an estimated $52K sold.
- 12 institutional investors held Zomedica Corp. (ZOM) as of Q1 2018, up from 9 in Q4 2017.
- Funds reported $1.61M of Zomedica Corp. stock for Q1 2018, up 133% quarter-over-quarter.
- 4 funds opened new Zomedica Corp. positions in Q1 2018 and 1 closed out, a net change of +3 holders.
- The largest Zomedica Corp. buyer in Q1 2018 was Millennium Management, an estimated $708K added.
- The largest Zomedica Corp. seller in Q1 2018 was Citadel Advisors, an estimated $52K sold.
Based on aggregated 13F filings for Q1 2018.